First anticoagulant approved for preventing VTE recurrence in children
(HealthDay)—Fragmin (dalteparin sodium) injection has been granted the first approval for subcutaneous use in preventing recurrence of symptomatic venous thromboembolism (VTE) in children aged 1 month or older, the U.S. ...
May 17, 2019
0
1